Rimiterol

Rimiterol
Systematic (IUPAC) name
4-{(S)-hydroxy[(2R)-piperidin-2-yl]methyl}benzene-1,2-diol
Identifiers
CAS Number 32953-89-2 N
ATC code R03AC05 (WHO)
PubChem CID 36283
ChemSpider 33366 YesY
UNII 26GIW6ZLPH YesY
ChEMBL CHEMBL1097630 N
Chemical data
Formula C12H17NO3
Molar mass 223.268 g/mol
 NYesY (what is this?)  (verify)

Rimiterol (INN/USAN) is a third-generation[1] short-acting[2][3] β2 agonist.

Synthesis

G. H. Sankey, K. D. E. Whiting, DE 2024049; idem, US 3910934 (1970, 1975 to 3M); C. Kaiser, S. T. Ross, DE 2047937; idem, US 3705169 (1971, 1972 to SK & F); G. H. Sankey, K. D. E. Whiting, J. Heterocycl. Chem. 9, 1049 (1972).

References

  1. Palma-Carlos, A. G.; Palma-Carlos, G. S. (1986). "Beta-2-agonists of Third Generation". Allergie et Immunologie 18 (4): 31–32, 35. PMID 2899434.
  2. Lai, CK; Twentyman, OP; Holgate, ST (October 1989). "The Effect of an Increase in Inhaled Allergen Dose After Rimiterol Hydrobromide on the Occurrence and Magnitude of the Late Asthmatic Response and the Associated Change in Nonspecific Bronchial Responsiveness". The American Review of Respiratory Disease 140 (4): 917–23. PMID 2572192.
  3. Ydreborg, SO; Svedmyr, N; Thiringer, G (April 1977). "Comparison of Rimiterol and Terbutaline, Given by Aerosol, in a Long-term Study". Scandinavian Journal of Respiratory Diseases 58 (2): 117–24. PMID 16339.
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.